Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

India

 

Cheap lessons from Emerging Markets

Operators in emerging markets continue to innovate and drive down the price of care through creative business models and the use of technology. In doing so, they are the resolving the tensions between access, quality and cost. But healthcare in the rich world is lagging behind. A panel of speakers at our annual conference identified the key lessons that Europe needs to learn and why they fail to do so.

SRL plans African strategy

Indian lab group SRL is close to deal in Nigeria for a second Africa lab hub and a third is planned for Kenya. Its Congo lab already serves seven countries, CEO Sanjeev Vashishta told Healthcare Nova at the Healthcare Business International 2016 conference.

Paras launches maternity chain

Paras Hospitals in Northern India plans to roll out a chain of specialist outpatient maternity centres. It is one of several hospital chains which are rapidly deploying specialist outpatient chains in a race to quickly reach new consumers.

Thyrocare to IPO

India’s fourth largest lab group, Thyrocare, will list in Mumbai on April 27. It hopes to raise INR 480 crore (US$ 72.2m) with shares priced at 420-446 rupees. Mauritian private equity group CX Partners will sell 90% of its holding and the rest is from the firm’s promoters.

IFC backs Regency Hospital to expand in Uttar Pradesh

The World Bank's investment arm International Finance Corporation (IFC) is backing an Rs 160 crore ($24m) investment to expand Regency Hospital in Kanpur, India. The plan is to open a new secondary hospital and an oncology centre run jointly with Bangalore-based cancer specialist Health Care Global (HCG). Regency will also expand across Uttar Pradesh with new hospitals in Lucknow and Allahabad.

Interview: Dr Sanjeev Kanoria

An ex-McKinsey consultant and a liver surgeon by training, Sanjeev is one of four brothers running a family conglomerate which is the second largest non-banking financial institution in India. He is also chairman of Advinia healthcare, a chain of 16 UK care homes which he founded in 1999 with his wife sangita. In 2017, he will launch a brand new 400 bed, multi-specialist hospital in New Mumbai, India, which plans a stream of joint ventures with specialist providers.

Medicover in bold Indian IVF move

The pan-European operator, Medicover, which has lines in occupational healthcare, labs, ambulances, fertility and more, is to open 50 IVF clinics in India within five years at a cost of US$100m. In just four months, it’s planning four clinics in the National Capital Region (NCR) and from there it will expand across the north, building ten outlets within 18 months. Fredrik Ragmark, CEO of Medicover, explained this out of character move to us.

Rating and booking sites: Threats or Friends?

There are growing signs that a new generation of rating and booking websites will change the face of outpatient care in many Emerging Markets. New players, sometimes backed by hundreds of millions of dollars, are investing in telehealth platforms that promise instant access to patients, partnering with pharmacies and making access to healthcare easier for patients. Some are active in dozens of countries. Here we talk to the major players about their strategies and how they see the market.

Apollo Sugar to open 30 clinics this year

The specialist Indian diabetes group, Apollo Sugar, plans to open 30 new clinics in five cities this fiscal year. The JV between Apollo Hospitals and pharma giant Sanofi is moving into second-tier Indian cities by opening smaller clinics funded by internal accruals and spare capital. “This model is more capital efficient,” CEO Gagan Bhalla told the local press.

Abraaj close to $1bn target

Abraaj is close to its $1bn target for its mammoth Global Healthcare Fund. And its ambitions are becoming clearer.

Find Us